Denali Therapeutics
Patents, Design & Utilities
Last updated:
List of all Denali Therapeutics patents 70 in total
| Status | Patent |
|---|---|
Application | Utility: MODIFIED RELEASE FORMULATION OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF TREATMENT Filling date: 28 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: PROGRANULIN VARIANTS Filling date: 28 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: COMPOUNDS, COMPOSITIONS, AND METHODS Filling date: 28 Sep 2025 Issue date: 14 Jul 2022 |
Application | Utility: PROGRANULIN VARIANTS Filling date: 28 Sep 2025 Issue date: 7 Jul 2022 |
Grant | Utility: Anti-Tau antibodies and methods of use thereof Filling date: 28 Sep 2025 Issue date: 28 Jun 2022 |
Application | Utility: FORMULATIONS OF PROTEIN MOLECULES COMPRISING IDURONATE 2-SULFATASE Filling date: 28 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: COMPOUNDS, COMPOSITIONS AND METHODS Filling date: 28 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: COMPOUNDS, COMPOSITIONS AND METHODS Filling date: 28 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: COMPOUNDS, COMPOSITIONS, AND METHODS Filling date: 28 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: COMPOUND, COMPOSITIONS, AND METHODS Filling date: 28 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Compounds, compositions and methods Filling date: 28 Sep 2025 Issue date: 19 Apr 2022 |
Application | Utility: ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 10 Mar 2022 |
Application | Utility: Kinase Inhibitors and Uses Thereof Filling date: 28 Sep 2025 Issue date: 10 Feb 2022 |
Grant | Utility: Modulators of eukaryotic initiation factor 2B, compositions and methods Filling date: 28 Sep 2025 Issue date: 1 Feb 2022 |
Application | Utility: Compounds, Compositions and Methods Filling date: 28 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: LYSOSOMAL STORAGE DISORDER BIOMARKERS AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: METHODS FOR TREATING DYSREGULATED LIPID METABOLISM Filling date: 28 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: ENGINEERED BISPECIFIC PROTEINS Filling date: 28 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: ANTI-HER2 POLYPEPTIDES AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 6 Jan 2022 |
Grant | Utility: Compound, compositions, and methods Filling date: 28 Sep 2025 Issue date: 4 Jan 2022 |
Application | Utility: METHODS FOR TREATING AND MONITORING PROGRANULIN-ASSOCIATED DISORDERS Filling date: 28 Sep 2025 Issue date: 23 Dec 2021 |
Grant | Utility: Kinase inhibitors and uses thereof Filling date: 28 Sep 2025 Issue date: 21 Dec 2021 |
Grant | Utility: Compounds, compositions and methods Filling date: 28 Sep 2025 Issue date: 16 Nov 2021 |
Application | Utility: Compounds, Compositions and Methods Filling date: 28 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: SUBSTITUTED PYRIMIDINES AS LRKK2 INHIBITORS Filling date: 28 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: COMPOUNDS, COMPOSITIONS AND METHODS Filling date: 28 Sep 2025 Issue date: 23 Sep 2021 |
Grant | Utility: Anti-TREM2 antibodies and methods of use thereof Filling date: 28 Sep 2025 Issue date: 21 Sep 2021 |
Grant | Utility: Anti-ApoE antibodies Filling date: 28 Sep 2025 Issue date: 21 Sep 2021 |
Application | Utility: FUSION PROTEINS COMPRISING PROGRANULIN Filling date: 28 Sep 2025 Issue date: 16 Sep 2021 |
Grant | Utility: Compounds, compositions, and methods Filling date: 28 Sep 2025 Issue date: 7 Sep 2021 |
Grant | Utility: Compounds, compositions and methods Filling date: 28 Sep 2025 Issue date: 27 Jul 2021 |
Application | Utility: ANTI-TREM2 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: FUSION PROTEINS COMPRISING ENZYME REPLACEMENT THERAPY ENZYMES Filling date: 28 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: PROGRANULIN VARIANTS Filling date: 28 Sep 2025 Issue date: 24 Jun 2021 |
Grant | Utility: Substituted pyrimidines as LRKK2 inhibitors Filling date: 28 Sep 2025 Issue date: 8 Jun 2021 |
Application | Utility: COMPOUNDS, COMPOSITIONS AND METHODS Filling date: 28 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: PHOSPHO-RAB ANTIBODIES, ASSAYS AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: TRANSFERRIN RECEPTOR-BINDING POLYPEPTIDES AND USES THEREOF Filling date: 28 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: MODULATORS OF EUKARYOTIC INITIATION FACTOR 2 Filling date: 28 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: POLYMORPHS AND SOLID FORMS OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF PRODUCTION Filling date: 28 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: ANTI-BACE1 ANTIBODIES AND METHODS OF USE THEREOF Filling date: 28 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: PROCESS FOR THE PREPARATION OF PYRIMIDINYL-4-AMINOPYRAZOLE COMPOUNDS Filling date: 28 Sep 2025 Issue date: 14 Jan 2021 |
Application | Utility: COMPOUNDS, COMPOSITIONS, AND METHODS Filling date: 28 Sep 2025 Issue date: 7 Jan 2021 |
Grant | Utility: Fusion proteins comprising enzyme replacement therapy enzymes Filling date: 28 Sep 2025 Issue date: 22 Dec 2020 |
Grant | Utility: Polymorphs and solid forms of a pyrimidinylamino-pyrazole compound, and methods of production Filling date: 28 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: ENGINEERED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES Filling date: 28 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: COMPOUNDS, COMPOSITIONS AND METHODS Filling date: 28 Sep 2025 Issue date: 22 Oct 2020 |
Application | Utility: Compounds, Compositions and Methods Filling date: 28 Sep 2025 Issue date: 8 Oct 2020 |
Showing 1 to 50 of 70 patents.